Please login to the form below
Aptalis
This page shows the latest Aptalis news and features for those working in and with pharma, biotech and healthcare.
HIV prevention pill heads July CHMP recommendations
Other positive recommendations were given for Aptalis' Truberzi (eluxadoline) as a treatment for irritable bowel syndrome with diarrhoea, along with two biosimilar versions of Sanofi's clot-busting drug Lovenox (enoxaparin) -
Latest news
-
Actavis claims top UK generics spot with Auden Mckenzie buy
Other acquisitions in the last 12 months have included $25bn for Forest Laboratories, $2.9bn for Aptalis, a $1.6bn deal for Furiex Pharma and $675m for Durata.
-
Forest Labs agrees $1.46bn deal to buy Furiex
Forest chief executive Brent Saunders said the Furiex deal "is a natural extension of our GI business following our $2.9bn acquisition of Aptalis earlier this year," adding that eluxadoline would
-
Forest said to be interested in $3bn Aptalis acquisition
Forest said to be interested in $3bn Aptalis acquisition. Deal would give pharma company ownership of cystic fibrosis and gastrointestinal products. ... The Aptalis rumour also comes shortly after Forest itself was the subject of speculation about a
-
Par Pharma acquired by investment firm for $1.9bn
TPG has several major healthcare investments already, with stakes in firms such as Aptalis Pharma, Biomet, Immucor, IMS Health and Quintiles Transnational, and the acquisition of Par provides the company with
More from news
Approximately 2 fully matching, plus 3 partially matching documents found.
Latest Intelligence
-
Pharma deals during February 2014
The deal is expected to close mid 2014, pending approvals. The announcement came just after Forest completed its acquisition of Aptalis last month for $3bn and this month sold a number
-
Pharma deals during January 2014
Almost right to the end of the month, the big headline deal was that of Forest with its planned takeover of Aptalis. ... Aptalis itself was only formed in 2011 following the acquisition of Eurand by the Montreal based Axcan Pharma.
-
Deal Watch table for January 2014
4, 295. Aptalis/ Forest. Company acquisition. Acquiring sales turnover of $688m. 2, 900.
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest appointments
-
Intellia Therapeutics appoints Dr Moncef Slaoui and Dr Frank Verwiel
He has held numerous leadership roles including president and CEO of Aptalis Pharma prior to its acquisition by Forest Laboratories.
-
Lupin names chief corporate development officer
Lupin names chief corporate development officer. Theresa Stevens has experience at Novartis and Aptalis. ... Stevens joins the India-based pharma company from Aptalis Pharma, where she was chief corporate development officer for mergers and acquisitions,
-
Marino Garcia joins Synergy Pharmaceuticals
Marino Garcia joins Synergy Pharmaceuticals. He has experience in gastrointestinal market at Aptalis. ... Prior to his time at Aptalis Garcia was VP of US commercial operations and new product development at Aspreva Pharmaceuticals.
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Featured jobs
-
Senior Programme Executive
-
Salary TBC
- Head of Operations/ BUD, Healthcare PR, London – Excellent leade...
-
Excellent Package
- Account Manager – Med Comms – London
-
Salary TBC
- Senior Account Manager / Account Director
-
Great salary and bebefits
- Editor > Senior Editor – Medical Education – London
-
Very competitive with excellent benefits
-
Senior Medical Writer
-
Great salary and benefits
- Principal Medical Writer, Medical Communications, Relocate to Ca...
-
Excellent Salary
-
Senior Medical Writer
-
Great salary and bebefits
-
Scientific Director
-
Great salary and bebefits
- FREELANCE Account Manager – Creative Healthcare Advertising – Lo...
-
SUPERB DAY RATES AVAILABLE
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
- Senior / Principal Regulatory Writer – Home Working - UK or US
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
- Senior Account Manager – Med Comms – Kent
-
Salary TBC
- Senior Medical Writer, Medical Communications, Relocate to Cardi...
-
Excellent Salary
- FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...
-
EXCELLENT DAY RATES AVAILABLE
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
Subscribe to our email news alerts
PMHub
Four Health Communications
Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...
Latest intelligence
- Pharma’s isolated islands of innovation
- With service design and technology often failing the patient, why perspective on improving outcomes need to change...
- Uncertainty, austerity and Brexit
- What does it mean for the life science sector?...
- The Holy Grail of HCP Access
- This is the data you need to gain access....
Quick links
Infographics
